Screening for impaired glucose tolerance - Results from a population-based study in 21,057 individuals

被引:57
作者
Lindahl, B [1 ]
Weinehall, L [1 ]
Asplund, K [1 ]
Hallmans, G [1 ]
机构
[1] Umea Univ, Dept Publ Hlth & Clin Med, S-90185 Umea, Sweden
关键词
D O I
10.2337/diacare.22.12.1988
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To study the distribution of fasting plasma glucose and impaired glucose tolerance (IGT) in a large general population and explore their possible implications for large-scale screening. The study focuses especially on the relation to age, obesity, and heredity background of diabetes. RESEARCH DESIGN AND METHODS - A total of 21,057 men and women aged 30-60 years were used for this cross-sectional study. Individuals with known diabetes and individuals with a fasting plasma glucose greater than or equal to 7 mmol/l were excluded. A physical examination, including blood sampling and an oral glucose tolerance test, was conducted. RESULTS - The relative risk for IGT increased more than fourfold among obese subjects compared with normal-weight subjects, yet only 25% of IGT subjects were obese. Similarly IGT subjects more frequently reported having first-degree relatives with diabetes than did subjects with normal glucose tolerance. Nonetheless, >70% of IGT subjects reported no heredity background of diabetes. Subjects with IGT showed higher mean values of BMI, blood pressure, and triglycerides. Only 13% of the men and 19% of the women having impaired fasting glucose (IFG) fulfilled the criteria of IGT. CONCLUSIONS - The present study shows that a high-risk screening strategy for IGT targeted solely toward subjects with obesity and/or heredity background of diabetes will Fail to detect the majority of subjects with IGT in the general population. The new concept of IFG may not replace the concept of IGT as a risk marker for worsening to diabetes.
引用
收藏
页码:1988 / 1992
页数:5
相关论文
共 30 条
[1]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[2]  
2-S
[3]   METABOLIC AND GENETIC-CHARACTERIZATION OF PREDIABETIC STATES - SEQUENCE OF EVENTS LEADING TO NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
BECKNIELSEN, H ;
GROOP, LC .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (05) :1714-1721
[4]   LOSS OF THE 1ST PHASE INSULIN-RESPONSE TO INTRAVENOUS GLUCOSE IN SUBJECTS WITH PERSISTENT IMPAIRED GLUCOSE-TOLERANCE [J].
DAVIES, MJ ;
RAYMAN, G ;
GRENFELL, A ;
GRAY, IP ;
DAY, JL ;
HALES, CN .
DIABETIC MEDICINE, 1994, 11 (05) :432-436
[5]   INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE [J].
DEFRONZO, RA ;
FERRANNINI, E .
DIABETES CARE, 1991, 14 (03) :173-194
[6]   PATHOGENESIS OF NIDDM - A BALANCED OVERVIEW [J].
DEFRONZO, RA ;
BONADONNA, RC ;
FERRANNINI, E .
DIABETES CARE, 1992, 15 (03) :318-368
[7]   Predictors of progression from impaired glucose tolerance to NIDDM - An analysis of six prospective studies [J].
Edelstein, SL ;
Knowler, WC ;
Bain, RP ;
Andres, R ;
BarrettConnor, EL ;
Dowse, GK ;
Haffner, SM ;
Pettitt, DJ ;
Sorkin, JD ;
Muller, DC ;
Collins, VR ;
Hamman, RF .
DIABETES, 1997, 46 (04) :701-710
[8]   EARLY METABOLIC DEFECTS IN PERSONS AT INCREASED RISK FOR NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
ERIKSSON, J ;
FRANSSILAKALLUNKI, A ;
EKSTRAND, A ;
SALORANTA, C ;
WIDEN, E ;
SCHALIN, C ;
GROOP, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (06) :337-343
[9]   HYPERINSULINEMIA - THE KEY FEATURE OF A CARDIOVASCULAR AND METABOLIC SYNDROME [J].
FERRANNINI, E ;
HAFFNER, SM ;
MITCHELL, BD ;
STERN, MP .
DIABETOLOGIA, 1991, 34 (06) :416-422
[10]   THE ABBREVIATED GLUCOSE-TOLERANCE TEST IN SCREENING FOR DIABETES - THE ISLINGTON DIABETES SURVEY [J].
FORREST, RD ;
JACKSON, CA ;
YUDKIN, JS .
DIABETIC MEDICINE, 1988, 5 (06) :557-561